- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.9 | - |
NAV | ₹41.85 | - |
Fund Started | 12 Nov 2018 | - |
Fund Size | ₹3339.79 Cr | - |
Exit Load | Exit load of 0.50% if redeemed within 1 month. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.9
-
NAV
₹41.85
-
Fund Started
12 Nov 2018
-
Fund Size
₹3339.79 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 1 month.
-
Returns
1 Year | 39.37% | - |
3 Year | 21.83% | - |
5 Year | 30.66% | - |
1 Year
39.37%
-
3 Year
21.83%
-
5 Year
30.66%
-
Holding Analysis
Equity | 94.51% | - |
Cash | 5.49% | - |
Equity
94.51%
-
Cash
5.49%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.28% |
Suven Pharmaceuticals Ltd. | 10.01% |
Cipla Ltd. | 7.86% |
Ipca Laboratories Ltd. | 7.62% |
Globus Medical Inc | 5.98% |
Illumina Inc. (USA) | 5.23% |
Alembic Pharmaceuticals Ltd. | 4.79% |
Gland Pharma Ltd. | 4.40% |
Apollo Hospitals Enterprise Ltd. | 3.91% |
Concord Biotech Ltd. | 3.82% |
-
Fund Manager
Name | Jay Kothari | - |
Start Date | 16 Mar 2018 | - |
Name
Jay Kothari
-
Start Date
16 Mar 2018
-
About Fund
Description | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. | - |
Launch Date | 12 Nov 2018 | - |
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
12 Nov 2018
-
